Popularized by the hit TV show Breaking Bad, the protein Ricin is well known as one of the most common and toxic biological molecules. In a recent review published in the journal Toxins by Letizia Polito, the dangers and possible therapeutic effects are covered as well as the mechanism of action. Traces of ricin have been found as long as 24,000 years ago in a purified form and have been present in medical use dating as far back as 1500 B.C. in Egypt. Coming from the castor oil plant, the castor bean presents a source of easy purification which has led to added fear of Ricin. This combination has led to Ricin being labeled as a Category B substance. As for its bioterrorism capabilities, the toxin becomes impractical as eight tons would have to be aerosolized over a 100 km2 space for a 50% casualty, as compared to anthrax which requires only one kg for the same effect. However, ricin has been shown to inhibit cellular protein synthesis by 50% at doses from 0.1-1 pM, meaning it would be lethal in humans from ~5-10 chewed beans. Medically, Ricin has proven its worth as a laxative, diuretic, anti-inflammatory, and abortifacient, with promising research as an anti-cancer therapy. Due to its non-specific binding mechanism Ricin requires a carrier, typically an antibody, to form a conjugate called an immunotoxin. These immunotoxins have been shown in both pre-clinical and clinical studies to be effective toward different cancer types both in vitro and in vivo for humans. Part of the continued negatives of these treatments are the continued unspecific toxicity, organ toxicity, immunogenicity, fast removal from blood stream, and lysosomal degradation inside cells.
Ricin falls under the category of a “ribosome-inactivating protein” (RIP), and is specifically a Type 2 RIP. This means the protein contains two different chains, with the B-chain allowing easier entry into cells, making it potentially more dangerous. The mechanism of action for Ricin is the deletion of a single adenine base from the large subunit ribosomal sarcin-ricin RNA loop (SRL). This deletion of a highly conserved structure leads to a blockage of GTP hydrolysis and impedes translational machinery. This impeding of translational machinery appears to be what leads to cell, and organism, death.
Despite the bad name Ricin gets as a toxin, the possibility as an anti-cancer therapeutic lends itself to being a protein worth continued research.